<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The objective of the study was to provide observational clinical data on <z:chebi fb="4" ids="35471">psychotropic drugs</z:chebi> used in older people with <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental illness</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This was an observational, single-centre, one-week prevalence study of <z:e sem="disease" ids="C0852553" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychiatric symptoms</z:e>, disorders and <z:chebi fb="4" ids="35471">psychotropic drug</z:chebi> use in older with <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental illness</z:e> cared for by the South West people Yorkshire Mental Health NHS Trust (Wakefield Locality), UK </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical assessment included completion of the <z:hpo ids='HP_0000709'>Psychosis</z:hpo> Evaluation Tool for Common use by Caregivers </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A total of 593/660 older patients with <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental illness</z:e> (mean +/- SD age, 76 +/- 8.1 years were assessed </plain></SENT>
<SENT sid="4" pm="."><plain>44.5% had <z:hpo ids='HP_0000726'>dementia</z:hpo> (excluding vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>) and 33.7% had a <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorder</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Of the total, 20.4% did not receive <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> active medication </plain></SENT>
<SENT sid="6" pm="."><plain>Of those receiving <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> active medication approximately half (51.3%) took <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> and 46.2% antidepressants </plain></SENT>
<SENT sid="7" pm="."><plain>Of 304 patients taking <z:chebi fb="0" ids="35476">antipsychotics</z:chebi>, 87% took only one medication </plain></SENT>
<SENT sid="8" pm="."><plain>However, patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and related disorders were significantly more likely to be prescribed two or more <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> (p &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="8871">Risperidone</z:chebi> was the most frequently prescribed antipsychotic (n = 136, 44.7%) </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="8871">Risperidone</z:chebi> doses were significantly lower for patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorders</z:e> than with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> (p &lt; 0.002) </plain></SENT>
<SENT sid="11" pm="."><plain>Side-effects from <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> were significantly greater in patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo>, suggesting a dose-related effect </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="8871">Risperidone</z:chebi> appeared to be well tolerated in <z:hpo ids='HP_0000001'>all</z:hpo> patients with no evidence of cerebrovascular side-effects in patients taking it </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: <z:chebi fb="4" ids="35471">Psychotropic drugs</z:chebi> were commonly used by older people in contact with mental health services </plain></SENT>
<SENT sid="14" pm="."><plain>The doses of <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> used in <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">affective disorders</z:e> were significantly lower than in <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain><z:chebi fb="0" ids="8871">Risperidone</z:chebi> was the most commonly used drug in <z:hpo ids='HP_0000001'>all</z:hpo> diagnostic groups including <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="16" pm="."><plain>Despite a relatively large numbers of patients receiving <z:chebi fb="0" ids="8871">risperidone</z:chebi> in this naturalistic study, no serious side-effects were reported or identified </plain></SENT>
<SENT sid="17" pm="."><plain>In this paper we focus our findings on <z:chebi fb="0" ids="35476">antipsychotics</z:chebi> in the light of recent advice from the Committee on Safety of Medicines (UK) </plain></SENT>
</text></document>